Estrogen treatment increases the levels of regulator of G protein signaling-Z1 in the hypothalamic paraventricular nucleus: possible role in desensitization of 5-hydroxytryptamine1A receptors
- 1 January 2004
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 127 (2) , 261-267
- https://doi.org/10.1016/j.neuroscience.2004.05.031
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A Region-Specific Increase in Gαq And Gα11 Proteins in Brains of Rats during Cocaine WithdrawalThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administrationLife Sciences, 2003
- RGSZ1 and Ret RGS: Two of Several Splice Variants from the Gene RGS20Genomics, 2001
- Acute and chronic effects of citalopram on postsynaptic 5‐hydroxytryptamine1A receptor‐mediated feedback: a microdialysis study in the amygdalaJournal of Neurochemistry, 2001
- Fluoxetine efficacy in menopausal women with and without estrogen replacementJournal of Affective Disorders, 1999
- RGSZ1, a Gz-selective Regulator of G Protein Signaling Whose Action Is Sensitive to the Phosphorylation State of GzαPublished by Elsevier ,1998
- Blunted 5 -HT1A-receptor agonist-induced corticotropin and cortisol responses after long- term ipsapirone and fluoxetine administration to healthy subjects*Clinical Pharmacology & Therapeutics, 1998
- GAIP and RGS4 Are GTPase-Activating Proteins for the Gi Subfamily of G Protein α SubunitsCell, 1996
- Estrogen augments serotonergic activity in postmenopausal womenBiological Psychiatry, 1995
- Effect of 5,7-Dihydroxytryptamine, Ovariectomy and Gonadal Steroids on Serotonin Receptor Binding in Rat BrainNeuroendocrinology, 1994